Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China's Central Finance Allocates RMB 10.4 Billion For Basic Healthcare Service Subsidies

This article was originally published in PharmAsia News

Executive Summary

China's central finance has allocated RMB 10.4 billion ($1.52 billion) to subsidize basic public healthcare services this year, a concrete step toward making such services freely accessible to all citizens. The healthcare reform plan has identified gradual standardization of basic public healthcare as one of five key reform measures from 2009 to 2011. The government aims to provide tangible benefits for citizens through transforming investment models, strengthening performance assessments and financial supervision, and raising fund disbursement benefits. To that end, relevant ministries or departments will progressively issue opinions, service specifications, fund management and performance effectiveness evaluation for basic healthcare uniformity. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072150

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel